Leptomeningeal metastases from breast cancer: Intrinsic subtypes may affect unique clinical manifestations

Breast Cancer Research and Treatment

Volumn 129, Issue 3, 2011, Pages 809-817

  Lee, Soohyeon ^a   Ahn, Hee Kyung ^a   Park, Yeon Hee ^a   Nam, Do Hyun ^b   Lee, Jung Il ^b   Park, Won ^b   Choi, Doo Ho ^b   Huh, Seung Jae ^b   Park, Kyung Tae ^c   Ahn, Jin Seok ^a   Im, Young Hyuck ^a  

^a Sungkyunkwan University   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

HER2; Leptomeningeal metastases; Subtype; Triple negative breast cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; TRASTUZUMAB;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; DISTANT METASTASIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENINGEAL METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL TIME;

ADENOCARCINOMA; ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MENINGEAL NEOPLASMS; MIDDLE AGED; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 80052590643     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1682-0     Document Type: Article

References (25)

1. NU Lin JR Bellon EP Winer 2004 CNS metastases in breast cancer J Clin Oncol 22 17 3608 3617 10.1200/JCO.2004.01 15337811 10.1200/JCO.2004.01.175 (Pubitemid 41103668)
2. YH Park MJ Park SH Ji SY Yi DH Lim DH Nam, et al. 2009 Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients Br J Cancer 100 6 894 900 6604941 19240719 10.1038/sj.bjc. 6604941 1:CAS:528:DC%2BD1MXjt1Gjsb8%3D
3. Chamberlain MC, Glantz M, Groves MD, Wilson WH. (2009) Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment. Semin Oncol. 36(4 Suppl 2):S35-45. doi:S0093-7754(09)00095-5
4. MC Chamberlain 2006 Neoplastic meningitis Neurologist 12 4 179 187 10.1097/01.nrl.0000219732.33321.cc 16832237 10.1097/01.nrl.0000219732.33321.cc (Pubitemid 44134044)
5. AG Mammoser MD Groves 2010 Biology and therapy of neoplastic meningitis Curr Oncol Rep 12 1 41 49 10.1007/s11912-009-0079-2 20425607 10.1007/s11912-009-0079-2
6. B Gleissner MC Chamberlain 2006 Neoplastic meningitis Lancet Neurol 5 5 443 452 S1474-4422(06)70443-4 16632315 10.1016/S1474-4422(06)70443-4
7. MJ Glantz BC Walters 1998 Diagnosis and outcome measures in trials for neoplastic meningitis: a review of the literature and clinical experience Neurosurg Focus 4 6 e4 040604 17154444 10.3171/foc.1998.4.6.7 1:STN:280:DC%2BD28jit1yitA%3D%3D
8. KA Jaeckle 2006 Neoplastic meningitis from systemic malignancies: diagnosis, prognosis and treatment Semin Oncol 33 3 312 323 S0093-7754(06)00190- 4 16769420 10.1053/j.seminoncol.2006.04.016 (Pubitemid 43849934)
9. GC Jayson A Howell 1996 Carcinomatous meningitis in solid tumours Ann Oncol 7 8 773 786 8922190 1:STN:280:DyaK2s%2FotVymtw%3D%3D (Pubitemid 26345867)
10. H Rudnicka A Niwinska M Murawska 2007 Breast cancer leptomeningeal metastasis-the role of multimodality treatment J Neurooncol 84 1 57 62 10.1007/s11060-007-9340-4 17310266 10.1007/s11060-007-9340-4 (Pubitemid 47103444)
11. SL Berg MC Chamberlain 2003 Systemic chemotherapy, intrathecal chemotherapy, and symptom management in the treatment of leptomeningeal metastasis Curr Oncol Rep 5 1 29 40 12493148 10.1007/s11912-003-0084-9 (Pubitemid 38898764)
12. LK Norris SA Grossman A Olivi 1997 Neoplastic meningitis following surgical resection of isolated cerebellar metastasis: a potentially preventable complication J Neurooncol 32 3 215 223 9049883 10.1023/A:1005723801479 1:STN:280:DyaK2s3gt1emtA%3D%3D (Pubitemid 27077972)
13. I Cokgor AH Friedman HS Friedman 2002 Current options for the treatment of neoplastic meningitis J Neurooncol 60 1 79 88 12416549 10.1023/A: 1020200317464 (Pubitemid 35153537)
14. EL Chang MH Maor 2003 Standard and novel radiotherapeutic approaches to neoplastic meningitis Curr Oncol Rep 5 1 24 28 12493147 10.1007/s11912-003-0083- x (Pubitemid 38898763)
15. W Boogerd MJ van den Bent PJ Koehler JJ Heimans JJ van der Sande NK Aaronson, et al. 2004 The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study Eur J Cancer 40 18 2726 2733 S0959-8049(04)00677-X 15571954 10.1016/j.ejca.2004.08.012 1:CAS:528:DC%2BD2cXhtVahurvE (Pubitemid 39574724)
16. L Recht S Phuphanich 2004 Treatment of neoplastic meningitis: what is the standard of care? Expert Rev Neurother 4 4 Suppl S11 S17 10.1586/14737175.4.4. S11 15853550 10.1586/14737175.4.4.S11 (Pubitemid 38962847)
17. F Clatot G Philippin-Lauridant MJ Ouvrier T Nakry S Laberge-Le-Couteulx C Guillemet, et al. 2009 Clinical improvement and survival in breast cancer leptomeningeal metastasis correlate with the cytologic response to intrathecal chemotherapy J Neurooncol 95 3 421 426 10.1007/s11060-009-9940-2 19557501 10.1007/s11060-009-9940-2 1:CAS:528:DC%2BD1MXhtlKitbrE
18. MC Chamberlain 2008 Neoplastic meningitis Oncologist 13 9 967 977 theoncologist.2008-0138 18776058 10.1634/theoncologist.2008-0138
19. MC Chamberlain M Glantz 2006 Ventriculoperitoneal shunt in patients with leptomeningeal metastasis Neurology 66 5 783 16534138 10.1212/01.wnl.0000205135. 85388.01
20. NU Lin EP Winer 2007 Brain metastases: the HER2 paradigm Clin Cancer Res 13 6 1648 1655 13/6/1648 17363517 10.1158/1078-0432.CCR-06-2478 1:CAS:528:DC%2BD2sXivV2gtro%3D (Pubitemid 46952930)
21. NU Lin E Claus J Sohl AR Razzak A Arnaout EP Winer 2008 Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases Cancer 113 10 2638 2645 10.1002/cncr.23930 18833576 10.1002/cncr.23930
22. Vincent T, Devita J (eds) (2011). Cancer principles & practice of oncology, 9th edn. Lippincott Williams & Wilkins, Philadelphia
23. CP Kokkoris 1983 Leptomeningeal carcinomatosis. How does cancer reach the pia-arachnoid? Cancer 51 1 154 160 6336971 10.1002/1097-0142(19830101)51: 1<154::AID-CNCR2820510130>3.0.CO;2-K 1:STN:280:DyaL3s7gt1KlsA%3D%3D (Pubitemid 13169591)
24. S Dawood K Broglio FJ Esteva NK Ibrahim SW Kau R Islam, et al. 2008 Defining prognosis for women with breast cancer and CNS metastases by HER2 status Ann Oncol 19 7 1242 1248 mdn036 18334512 10.1093/annonc/mdn036 1:STN:280:DC%2BD1cvgvVOkuw%3D%3D (Pubitemid 351911952)
25. R Bartsch A Rottenfusser C Wenzel K Dieckmann U Pluschnig G Altorjai, et al. 2007 Trastuzumab prolongs overall survival in patients with brain metastases from Her2 positive breast cancer J Neurooncol 85 3 311 317 10.1007/s11060-007- 9420-5 17557136 10.1007/s11060-007-9420-5 1:CAS:528:DC%2BD2sXhsVygt77E (Pubitemid 350142522)